Hepatic Ago1 appears to be unnecessary for obesity-induced pathophysiology, as it has been reported that deletion of hepatic Ago1 had no significant effect on weight gain, glucose tolerance, or insulin sensitivity under obese conditions (27). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.